Ki-20227

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameKi-20227
Drug Alias Namec-Fms tyrosine kinase inhibitor (Kirin)c-Fms tyrosine kinase inhibitor (Kyowa Hakko Kirin)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage Colony Stimulating Factor 1 inhibitorsProtein-tyrosine kinases inhibitors
TargetsMacrophage Colony Stimulating Factor 1Protein-tyrosine kinases
Therapy Area/IndicationsBone metastasesMultiple SclerosisBone Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKirin Brewery Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Kirin Co LtdKirin Brewery Company LtdKirin Pharma Co Ltd
Active IndicationsN/A
Inactive IndicationsBone metastasesMultiple SclerosisBone Diseases

Other Information

ATC CodeN/A
Related LinksN/A